Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Roman

Showing results (371-380 of 387) with videos related to

Pageof 39
Sort By:
Gynecologic Oncology|October 13, 2021
Results of TRIO-14, a phase II, multicenter, randomized, placebo-controlled trial of carboplatin-paclitaxel versus carboplatin-paclitaxel-ganitumab in newly diagnosed epithelial ovarian cancerG E Konecny, A E Wahner Hendrickson, T M Davidson, et al.
Environmental Research|April 22, 2026
Multigenerational exposure to per- and polyfluoroalkyl substances (PFAS) negatively impacts the reproductive health of male miceLeah Gillespie, Jacinta H Martin, Amanda L Anderson, et al.
Journal of Surgical Oncology|August 9, 2017
Impact of lympho-vascular space invasion on tumor characteristics and survival outcome of women with low-grade serous ovarian carcinomaKoji Matsuo, Kwong-Kwok Wong, Christina Fotopoulou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2019
A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian CancerAmit M Oza, Ursula A Matulonis, Angeles Alvarez Secord, et al.
Gynecologic Oncology|February 21, 2017
Impact of adjuvant therapy on recurrence patterns in stage I uterine carcinosarcomaKoji Matsuo, Kohei Omatsu, Malcolm S Ross, et al.
Gynecologic Oncology|October 24, 2017
Salvage chemotherapy with taxane and platinum for women with recurrent uterine carcinosarcomaKoji Matsuo, Malcolm S Ross, Mayu Yunokawa, et al.
JRSM Cardiovascular Disease|June 22, 2023
Comparison of the use of blood pressure telemonitoring versus standard medical care in the achievement of short-term therapeutic goals in blood pressure in patients with uncontrolled hypertension: An open-label clinical trialM G Ramos-Zavala, F Grover-Páez, E G Cardona-Muñoz, et al.
Gynecologic Oncology|December 10, 2016
Tumor characteristics and survival outcomes of women with tamoxifen-related uterine carcinosarcomaKoji Matsuo, Malcolm S Ross, Stephen H Bush, et al.
Journal of Surgical Oncology|October 19, 2017
Survival outcome of women with stage IV uterine carcinosarcoma who received neoadjuvant chemotherapy followed by surgeryKoji Matsuo, Marian S Johnson, Dwight D Im, et al.
Gynecologic Oncology|December 18, 2017
Significance of venous thromboembolism in women with uterine carcinosarcomaKoji Matsuo, Malcolm S Ross, Dwight D Im, et al.
Pageof 39

Showing results (371-380 of 387) with videos related to

Sort By:
Pageof 39
Gynecologic Oncology|October 13, 2021
Results of TRIO-14, a phase II, multicenter, randomized, placebo-controlled trial of carboplatin-paclitaxel versus carboplatin-paclitaxel-ganitumab in newly diagnosed epithelial ovarian cancerG E Konecny, A E Wahner Hendrickson, T M Davidson, et al.
Environmental Research|April 22, 2026
Multigenerational exposure to per- and polyfluoroalkyl substances (PFAS) negatively impacts the reproductive health of male miceLeah Gillespie, Jacinta H Martin, Amanda L Anderson, et al.
Journal of Surgical Oncology|August 9, 2017
Impact of lympho-vascular space invasion on tumor characteristics and survival outcome of women with low-grade serous ovarian carcinomaKoji Matsuo, Kwong-Kwok Wong, Christina Fotopoulou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2019
A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian CancerAmit M Oza, Ursula A Matulonis, Angeles Alvarez Secord, et al.
Gynecologic Oncology|February 21, 2017
Impact of adjuvant therapy on recurrence patterns in stage I uterine carcinosarcomaKoji Matsuo, Kohei Omatsu, Malcolm S Ross, et al.
Gynecologic Oncology|October 24, 2017
Salvage chemotherapy with taxane and platinum for women with recurrent uterine carcinosarcomaKoji Matsuo, Malcolm S Ross, Mayu Yunokawa, et al.
JRSM Cardiovascular Disease|June 22, 2023
Comparison of the use of blood pressure telemonitoring versus standard medical care in the achievement of short-term therapeutic goals in blood pressure in patients with uncontrolled hypertension: An open-label clinical trialM G Ramos-Zavala, F Grover-Páez, E G Cardona-Muñoz, et al.
Gynecologic Oncology|December 10, 2016
Tumor characteristics and survival outcomes of women with tamoxifen-related uterine carcinosarcomaKoji Matsuo, Malcolm S Ross, Stephen H Bush, et al.
Journal of Surgical Oncology|October 19, 2017
Survival outcome of women with stage IV uterine carcinosarcoma who received neoadjuvant chemotherapy followed by surgeryKoji Matsuo, Marian S Johnson, Dwight D Im, et al.
Gynecologic Oncology|December 18, 2017
Significance of venous thromboembolism in women with uterine carcinosarcomaKoji Matsuo, Malcolm S Ross, Dwight D Im, et al.
Pageof 39